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Role of Inflammatory Factors in 
Regulation of Osteogenesis in 
Tissue-Engineered Bone
Yandong Mu, Lu Yang, Chenglong Li and Wei Qing
Abstract
It was traditionally considered that the inhibition of inflammatory reaction is 
necessary for osteogenesis, but the latest issue argued inflammation is unavoidable 
in the process of bone trauma, and physiological inflammatory reaction is essential 
to achieve bone formation. Tissue-engineered bone graft is not only associated 
with osteoblast-related cells; the inflammatory reaction is the initial physiological 
process, mainly with neutrophil infiltration, which secretes MCP-1, IL-8, and other 
chemokines and further promotes dendritic cells, lymphocytes, and mononuclear 
macrophages to move in. The activation pathways of macrophages have a direct 
effect on the outcome of the inflammatory reaction and the healing, which are 
divided into the classical approach (M1) and the alternative approach (M2). The 
M1 pathway secretes IL-1 beta, IL-6, TNF-α, and other pro-inflammatory factors, 
while the M2 pathway secretes arginase, IL-1Ra, IL-4, and other anti-inflammatory 
cytokines, also with bone-healing-related growth factors, which promote homing of 
bone mesenchymal stem cells (bMSCs).
Keywords: tissue-engineered bone, osteogenesis, inflammatory factors, immune 
cells, osteoimmunology
1. Introduction
The human bone tissue has a certain self-healing ability, but for large bone 
defects, which measures up to more than 6–8 mm cannot self-repair. Currently, 
the main method for the treatment of large bone defects includes autograft and 
allograft, distraction osteogenesis, synthetic or natural material implanting, and 
bone tissue engineering [1–3]. Each method has its own advantages and disadvan-
tages. At present, the most commonly used autograft or allogeneic bone graft has 
good osteogenesis, but autologous bone transplantation can cause greater trauma 
to the donor site, while allograft bone will inevitably have an immune response or 
a potential biological safety risk [4–7]. Although distraction osteogenesis can avoid 
the trauma of the donor area, the course of treatment is too long [8]. Synthetic or 
natural materials are widely distributed, but their biocompatibility is low and can-
not participate in normal physiological metabolism [9, 10].
Bone tissue engineering is a new combination of life science and material science 
to establish human bone tissue reconstruction and recovery; its basic elements 
include seed cells, scaffold materials, growth factors, and biomechanics micro-
environment. When amplification of stem cells cultured in vitro adsorbed on the 
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biocompatibility biological material that can be absorbed by the body transplanted 
to the damaged bone site, accompanied by biological scaffold being absorbed, 
osteogenic differentiation, and secretion of matrix and mineralization occur, the 
formation of new bone and reconstruction take place [11]. The advantages of bone 
tissue engineering include no extra supply area damage, no graft rejection, and no 
risk of the spread of the disease [12], but currently this technique can only be able to 
regenerate and repair some tiny bone defects, and large bone defects still remain to 
be solved, while the main challenge is without an independent blood supply system, 
which provides nutrients and growth factor; also metabolite is transported by very 
limited diffusion and osmosis [13, 14].
Seed cells need to meet a wide range of sources, non-immunogenicity, and 
a strong ability to differentiate [15]. Currently, research is mainly focused on 
embryonic stem cells, bone marrow mesenchymal stem cells, dental pulp stem 
cells, and induced pluripotent stem cells [16]. Biological scaffold materials 
provide space for cell adhesion, proliferation, and differentiation and promote 
tissue regeneration. According to their source, biological scaffolds can be divided 
into natural material scaffolds and synthetic material scaffolds. Natural mate-
rial scaffolds include natural polymer materials, natural bone-derived materi-
als, and natural coral bone-derived materials which advantages include widely 
distributed, good degradation performance, and good biocompatibility; however, 
disadvantages cover low mechanical strength, high brittleness, and no bone 
induction. Research shows that cells can receive enough nutrients and oxygen by 
diffusion with the distance from the capillary by 20–200 μm but cannot meet the 
metabolic needs beyond this distance. With the increase of scaffold material size, 
the internal cell microenvironment, nutrition, and oxygen gradient decreased 
[17, 18]. Besides, isothermal conditions, proper pH value, and adequate nutrition 
supply are also important factors restricting the repair of large bone defects by 
tissue-engineered bone.
Growth factors regulate cell division, matrix synthesis, and tissue differentiation 
by autocrine and paracrine [19]. Study confirmed that growth factor is related to 
osteogenesis induced by bone morphogenetic protein, transforming growth factor 
beta, platelet-derived growth factor, and insulin-like growth factor, while bone 
morphogenetic protein in bone tissue engineering has the most significant effect 
[20]; an experiment proved that its application combined with vascular endothelial 
growth factor shows extraordinary effect of bone healing [21].
Once the tissue engineering materials are implanted in the area, the allogenic 
reaction is quickly triggered, showing aseptic inflammation, and starts the tis-
sue repair function. Tissue-engineered bone graft is not only associated with 
osteoblast-related cells; the inflammatory reaction is the first physiological process 
[22, 23]. Tissue engineering bone implantation is accompanied by an early inflam-
matory reaction, mainly with macrophages and neutrophil infiltration, which 
secretes MCP-1, IL-8, and other chemokines and further promotes dendritic cells, 
lymphocytes, and mononuclear macrophages to move in [24, 25]. As time goes on, 
neutrophils are gradually apoptotic and phagocytic by macrophages. The activation 
of macrophages has a direct effect on the outcome of the inflammatory reaction and 
the healing [26]. The activation pathway is divided into the classical approach (M1) 
and the alternative approach (M2). The M1 pathway secretes IL-1 beta, IL-6, TNF-
α, a pro-inflammatory factor, while the M2 pathway secretes arginase, IL-1Ra, IL-4, 
and other anti-inflammatory cytokines, also with bone-healing-related growth 
factors that promote homing of bMSCs [27].
Pathological inflammatory reaction can lead to failure of fibrous wrapping and 
bony binding. Chemokines and cytokines produced by physiological inflammatory 
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reaction, such as MCP-1 and VEGF, can promote osteogenesis and angiogenesis of 
bMSCs. Traditionally, the inhibition of inflammatory reaction is an important means 
of osteogenesis, but now, it has a deeper understanding of inflammatory response. 
Avoiding inflammatory reaction cannot achieve its goal; physiological inflammatory 
reaction is essential to achieve bone formation [28, 29].
Inflammation is unavoidable in the process of bone trauma; it is considered 
that inflammatory reaction plays a crucial role in the process of bone healing. The 
concept of osteoimmunology is attracting more and more attention. The immune 
system plays an important role in the skeletal system, and studies have shown that 
many diseases are closely related to the bone immune system. Kayal, R A suggests 
that periodontitis is closely related to bone immunity; in the fight against foreign 
microbes, inflammatory cells and inflammatory mediators also activate the protease 
to induce matrix degradation, resulting in bone resorption [30]. Kamiya, N found the 
active phase of Perthes disease (LCPD), and the increased IL-6 in the synovial fluid 
of the synovial joint was detected [31]. Cafiero, C found that chronic kidney disease 
is accompanied by abnormal verification and skeletal abnormalities, which may be 
related to the increased expression of nuclear factor kappa B receptor-activating 
factor ligand (RANKL) [32]. Metzger et al. [33] have found that inflammatory bowel 
disease (IBD) causes the inflammatory state of the body to cause bone loss. Spinal 
arthropathy and progressive ossification are also diseases caused by an abnormal 
bone immune system. HIV-infected persons show different degrees of bone-healing 
disorders. This also explains to some extent that the defects of the immune system 
have an important impact on bone healing [34]. What are the important inflamma-
tory factors involved in the process and the mechanism involved in osteogenesis? This 
article provides a framework.
2. Host initial immune response
Tissue-engineered bone graft always accompanies with implant surgery; at the 
same time, tissue damage is followed by a series of biochemical reactions at nano-
second level on the surface of biomaterial, which includes activation of coagulation, 
complement system, and immune system. Every step of these reactions signifi-
cantly determines the later physiological processes; we believe that early regulation, 
especially initial immune regulation, is potent for tissue prognosis.
2.1 Transient protein adsorption of biomaterial implanting
When implant surgery carried on, blood coagulation factors such as fibrinogen 
and factor XII can be absorbed on the biomaterial surface spontaneously, which 
initiate coagulation cascade; also with activation of platelets, tissue factor gener-
ated by damaged tissue amplifies this process. Complement is also capable of 
absorbing biomaterial, especially C3 and C3b. The complement synergistically 
interacts with coagulation cascade, which takes advantage of adherence of platelets. 
Immunoregulatory function has also been found in complement, which triggers 
leukocyte activation and mast cell degranulation [35, 36].
Other attachment proteins include fibronectin and vitronectin in the extracellular 
matrix, which have the ability to activate inflammatory response and also promote 
osteoblast adherence. It is also worth mentioning that danger signals, which named 
alarmins consist of ATP, uric acid, heat shock proteins, and so on, may activate 
immune cells through pattern recognition receptors (PRRs), mainly with Toll-like 
receptors [37].
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2.2 Acute inflammatory cell infiltration and pro-inflammatory factor release
Once the tissue damage occurs, polymorphonuclear leukocytes (PMNs) migrate 
to the damage site and initiate acute inflammation reflection. PMNs’ activation is 
associated with integrin and PRR attached on the surface protein of biomaterial 
[38]. PMNs secrete a series of cytokines, which usually lead to acute inflammation; 
IL-6, IL-8, and CCL2 are important factors which lead to proteolytic enzymes and 
ROS autocrine. IL-6 is produced by osteoblasts and stimulates osteoclasts to pro-
mote bone resorption. It acts by binding to soluble IL-6 receptor (sIL-6R) present in 
serum and acts as an agonist to promote ubiquitin/IL-6 signal transduction. IL-6 in 
the body has a role in regulating immune activity, acute phase reactions, and hema-
topoietic activity (Figure 1). CCL2, also named as monocyte chemotactic protein 1 
(MCP-1), has a strong chemotaxis function of recruiting monocytes which transfer 
into macrophages when reaching the inflammation site, also along with dendritic 
cells and lymphocytes. With continuous activation, PMNs undergo apoptosis within 
2 days and are swallowed by macrophages. As the most diverse histiocytes, mac-
rophages play an important role in the process of tissue remodeling [39]. It shows 
remarkable functional plasticity and plays a very different role in physiological and 
pathological environment. At present, macrophages are divided into classically 
activated (M1) and alternatively activated (M2) phenotypes, which are similar to 
Th1/Th2 subsets of helper T cells. Interferon γ (IFN-γ), lipopolysaccharide (LPS), 
and tumor necrosis factor-α (TNF-α) can activate the M1 phenotype, which subse-
quently secretes large quantities of pro-inflammatory cytokines such as IL-1β, IL-6, 
IL-23, TNF-α, arginine, inducible nitric oxide synthase (iNOS), and reactive oxygen 
species (ROS). In addition, lymphocytes, especially T cells, are proved to have an 
enhancement effect on macrophages [40–42].
Figure 1. 
IL-6 can bind to soluble IL-6 receptor (sIL-6R) present in serum and exerts its effect. IL-6 can activate two 
major signaling pathways, SHP2/MEK/ERK and SHP2/PI3K/Akt2, as well as JAK/STAT3 signaling pathways. 
IL-6 negatively regulates osteoblast differentiation through SHP2/MEK2/ERK and SHP2/PI3K/Akt2 pathways 
and positively regulates osteogenic differentiation through the JAK/STAT3 pathway.
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2.3 BMSCs’ chemotaxis
Endogenous bone marrow mesenchymal stem cells (BMSCs) have the ability 
to migrate spontaneously to the injured site and participate in the repair of cor-
responding tissues, and their directional migration depends on the interaction 
between chemoattractant molecules expressed locally and the corresponding 
receptors on the cell surface. After tissue injury, endogenous BMSCs moved 
out of the bone marrow, entered peripheral blood circulation and migrated to 
injured tissue, adhered to target vascular endothelial cells, and passed through 
the extracellular matrix barrier and get to the injured tissue to repair [43–46]. 
BMSCs are also capable to secrete a variety of growth factors that are conducive 
to the differentiation of hematopoietic stem cells such as IL-6, IL-11, granulocyte 
colony-stimulating factor (G-CSF), stem cell factor, and so on. Recent studies 
suggest that the main factors of chemotactic bone marrow mesenchymal stem cells 
are as follows: (1) Stromal cell-derived factor 1 (SDF-1) (Figure 2) can obviously 
enhance the chemotaxis function of BMSCs, the number of which is proportional 
to the gradient of SDF-1 concentration. Study showed that the expression of SDF-1 
was significantly increased after injury of the myocardium, liver, kidney, lung, 
and skin to form a difference in the concentration gradient with the bone marrow, 
so that it may play an important role in the directional migration of bone marrow 
mesenchymal stem cells [47]. (2) Monocyte chemoattractant protein 1 (MCP-1) 
Figure 2. 
Regulation of neovascularization by SDF-1. The chemokine SDF-1 is produced by hypoxic conditions, vascular 
injury, or tumors and is released in the circulation. SDF-1 signaling induces a complex remodeling of the BM 
microenvironment involving proteases, kit-ligand (KitL), and NO production, leading to mobilization of 
CXCR4+ angiogenic cells. Ultimately, SDF-1 expression in the neo-angiogenic niche recruits CXCR4+ cells 
and mediates their proper retention, differentiation, and pro-angiogenic activities in coordination with other 
angiogenic factors such as VEGF-A. Both PI3K/Akt and MAPK/ERK transduction pathways are involved 
in the enhancement of MSC migration induced via CXCR4. MSC migration was inhibited by AMD3100, 
LY294002, PD98059, and p38MAPK inhibitor (SB203580). Perturbing the SDF-1/CXCR4 signal axis affected 
the BMP2-induced osteogenic differentiation in mouse bone marrow-derived MSCs.
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is a multifunctional chemokine that plays an important role in inflammatory 
response, injury repair, and neovascularization. Recent studies have shown that 
MCP-1 can promote the migration of bone marrow mesenchymal stem cells to the 
injured site in animal models of cerebral ischemia injury [48]. (3) Granulocyte 
colony-stimulating factor (G-CSF): in recent years, it has been found that G-CSF 
can mobilize BMSCs into blood circulation and migrate to the injury site which can 
be blocked by antibodies against CXCR4. Whereas BMSCs also express CXCR4, 
G-CSF is mobilized through a similar mechanism that remains to be further 
confirmed [49]. (4) Mesenchymal metalloproteinase-9 (MMP-9): Endothelial 
cells, fibroblasts, and inflammatory cells release interstitial metalloproteinases 
during inflammation or hypoxia. Recent studies have revealed that BMSCs regulate 
the recovery, proliferation, and differentiation of hematopoietic stem cells and 
endothelial stem cells through the release of soluble Kit-ligand (sKitl) mediated by 
mesenchymal metalloproteinase-9 to promote the migration of BMSCs by mobiliz-
ing bone marrow mesenchymal stem cells into the peripheral blood [50, 51].
3. Host anti-inflammatory phase and healing
In the late stage of acute inflammation, the polymorphonuclear granulocytes 
were swallowed by macrophages, and the tissues were mainly infiltrated by mac-
rophages. Macrophages play a bidirectional role in the process of disease and tissue 
remodeling according to their different polarization function. Whether this action 
is positive or harmful depends on the transformation and balance between the 
polarization state of macrophage and the polarization state of M1/M2. For tissue 
engineering materials, the polarization of macrophages plays an important role 
in the function of macrophages. In view of the acute inflammatory response and 
infiltration of inflammatory macrophages that cannot be avoided in the early stages 
of implantation of bone implants, therefore, promoting the rapid and effective 
transformation of peri-implant inflammatory macrophages to M2 macrophages 
may be more helpful to promote bone healing and long-term stability of implants 
[42, 52, 53]. Good bone immune microenvironment can effectively promote 
osteogenic differentiation, while poor bone immune microenvironment can inhibit 
osteogenic differentiation, resulting in the formation of fibrous envelope.
3.1 Subside of acute inflammation and release of anti-inflammatory factors
Macrophages secrete a large number of bioactive factors under the certain action 
of tissue microenvironment. The types and secretion of these factors are closely 
related to the polarization and functional state of macrophages. Although there is 
still controversy, macrophages are divided into two major phenotypes: classically 
activated (M1) and alternatively activated (M2). This is very similar to the Th1/Th2 
subsets of helper T cells. M1 macrophages are activated by pro-inflammatory signals 
such as interferon γ (IFN-γ) alone or in conjunction with lipopolysaccharide (LPS) 
and tumor necrosis factor-α (TNF-α) in which main surface markers were CD80 and 
CCR7, also known as pro-inflammatory macrophages, which secreted pro-inflam-
matory cytokines such as TNF-α, IL-1 β, arginine, inducible nitric oxide synthase 
(iNOS), and reactive oxygen species (ROS), but rarely secreted anti-inflammatory 
factors such as IL-10. Its main role is to kill bacteria and other pathogens and 
participate in the Th1-type inflammation as both the initial and effector cells. The 
main markers of M2 macrophages are CD163 and CD206, also known as repair mac-
rophages. Macrophage differentiation to M2 was induced by alternative pathways 
such as IL-4, IL-10, and an immune complex (IC). M2 subtype can release IL-10, 
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IL-4, vascular endothelial growth factor (VEGF), platelet-derived growth factor BB 
(PDGF-BB), and transforming growth factor beta (TGF-β), which are beneficial to 
the formation and remodeling of new bone and extra cellular matrix (ECM) remod-
eling and angiogenesis [54–58]. The concentrations of pro-inflammatory factors 
such as IL-1 β, IL-6, and TNF-α (Figure 3) increased rapidly after trauma in order to 
initiate inflammation and bone repair in physiological environment and then gradu-
ally decreased and disappeared within 72 hours.
3.2 Osteogenesis of tissue engineering bone
Immune and vascularization are the key factors to regulate the osteogenesis of 
tissue engineering bone. Immune factors determine the inflammatory outcome and 
healing of the tissue. BMSCs have the ability to migrate spontaneously to the injured 
site and participate in the repair of corresponding tissues. BMSCs are a kind of low 
immunogenicity cells which can regulate the function of dendritic cells and T cells. It 
has the function of immune regulation and induction of immune tolerance and can 
improve and regulate the destructive inflammatory reaction [59, 60]. It is known that 
BMSCs secrete soluble factors through direct interaction between cells, inhibit the 
proliferation of T and B cells, inhibit the production of H2O2 secreted by neutrophils, 
and inhibit the cytotoxicity of T cells and NK cells. In vivo, BMSCs can differentiate 
into various tissue types when activated by various nutritional mechanisms, and 
the regeneration potential increases when exposed to the damaged environment. 
Cytokines such as IFN-α can regulate the homing and migration of BMSCs through 
the extracellular matrix [61]. Good vascularization can promote the supply of oxygen 
and nutrients, promote waste excretion, and accelerate the physiologic healing of 
tissue-engineered bone, which is another important factor in tissue engineering 
bone transplantation. Most of the tissues and cells in vivo are supplied with oxygen 
and nutrients by blood. Because of the limitation of oxygen diffusion in tissues, the 
oxygen supply range of capillaries can only be confined to the region of 100–200 μm 
[62]. Once implanted in vivo, the seed cells in the scaffold can only absorb oxygen 
Figure 3. 
TNF-α binds with TNFR1 or TNFR2 and initiates a series of signal transduction, among which FADD and 
NF-κB pathway determine the different destinies of the cell. The TRADD-FADD-caspase line causes apoptosis 
of the cell, and the TRAF2-RIP-IKKS line activates NF-κB and leads to cell survival. In fact, both routines are 
expressed in the cell at the same time; it is the ration of two pathways to codetermine the fate of the cell.
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and nutrients through the diffusion of adjacent capillaries in the early stage. After 
the large tissue-engineered bone is implanted in vivo, the demand for blood sup-
ply around the scaffold is higher. The current vascularization strategies include the 
modification of scaffolds, the introduction of growth factors, and the combined 
implantation of endothelial progenitor cells. Size and roughness of materials affect 
immune response. Dobrovolskaia found that M1 immunoreaction was mediated 
when particle diameter was larger than 1 mm, and M2 immunoreaction was mediated 
when particle diameter was smaller than 0.5 mm [63]. Barth and other studies found 
that the surface roughness of materials increased, and the tendency of macrophage 
differentiation to M2 increased significantly, which was beneficial to promote bone 
regeneration [64]. Ghrebi proved that the surface roughness of biomaterials could 
affect the morphology of macrophages by recognizing the ERK1/ERK2 pathway 
activated by the adhesion protein in macrophages [65]. It is known that vascular 
endothelial growth factor (VEGF) [66], basic fibroblast growth factor (bFGF) 
[67], platelet-derived growth factor (PDGF) [67], transforming growth factor beta 
(TGF-β), angiopoietin l (Ang-1), and other angiogenic growth factors can promote 
vascularization of tissue engineering complex implanted in vivo [68]. Kim et al. 
encapsulated VEGF in silica nanoparticles and released them after 28 days; the study 
showed that this method can effectively promote angiogenesis. Endothelial progeni-
tor cell, also known as angioblast, is involved not only in embryonic angiogenesis but 
also in embryonic angiogenesis [69]. Yu et al. co-cultured the endothelial progenitor 
cells derived from the bone marrow with osteoblasts and inoculated them on porous 
polycaprolactone hydroxyapatite to repair the 0.8 cm defect in the femur of rats. It 
was found that more capillaries and bone tissue were formed in the co-culture group 
than in the osteoblast group [70].
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